The herpes simplex virus type 1 (HSV-1) immediate-early phosphoprotein infected cell protein 0 (ICP0) is a potent transcriptional activator of viral genes and is required for efficient viral replication and reactivation from latency. However, it is largely unknown what role specific cellular factors play in the transactivator function of ICP0. With the long-term goal of identifying these factors, we developed a cell-based assay in a 96-well format to measure this activity of ICP0. We designed a system using a set of HSV-1 GFP reporter viruses in which the expression of GFP is potently induced by ICP0 in cell culture. The initial feasibility of this system was confirmed over a 24-hour period by fluorescence microscopy. We adapted this assay to a 96-well plate format, quantifying GFP expression with a fluorescence scanner. Our results indicate that the cell-based assay we developed is a valid and effective method for examining the transactivating activity of ICP0. This assay can be used to identify cellular factors that regulate the transactivating activity of ICP0.
Introduction
Herpes simplex virus type 1 (HSV-1) infects 70-80% of the population and commonly causes cold sores, although many infections are asymptomatic (Roizman, 2007) . HSV-1 can also cause ocular infections and is the major cause of infectious blindness in western industrialized countries (Roizman, 2007) . Initially, HSV-1 infects epithelial cells at a primary site, resulting in a lytic infection. The virus can then infect the sensory neurons that innervate the infected epithelial cells, where it establishes a life-long latent infection. Reactivation of latent virus can occur by different stresses, which initiates lytic infection in neurons and ultimately epithelial cells at the primary site of infection. This cycle of latent and lytic infections leads to recurrent disease. One viral protein that is important for efficient for viral replication and reactivation from latency is the immediate-early (IE) protein, infected cell protein 0 (ICP0) (Cai and Schaffer, 1989 , Harris et al., 1989 , Stow and Stow, 1986 .
ICP0 is one of the five HSV-1 IE proteins and has RING finger motif (Everett, 1989 , Meredith et al., 1995 that allows ICP0 to function as an E3 ubiquitin ligase (Boutell et al., 2002) . E3 ubiquitin ligases are components of an E1-E2-E3 biochemical pathway that conjugates and polymerizes chains of ubiquitin onto proteins (Kleiger and Mayor, 2014) . This activity of ICP0 directs the degradation of specific cellular proteins (Chelbi-Alix and de , Everett et al., 1998a , Lees-Miller et al., 1996 , Muller and Dejean, 1999 , Parkinson and Everett, 2000 , which in turn impairs cellular antiviral defenses. The E3 ubiquitin ligase activity of ICP0 is also linked to the ability of ICP0 to act as a potent global transcriptional activator of viral genes (Everett et al., 1998b , O'Rourke et al., 1998 . Previous studies have shown that the transactivation activity of ICP0 is important for efficient HSV-1 replication and reactivation from latency (Cai et al., 1993 , Cai and Schaffer, 1992 , Everett et al., 2009 . Although the transactivating activity of ICP0 has been studied in the absence of other IE genes in transient transfection assays (Davido et al., 2005 , Everett, 1987 , Jordan and Schaffer, 1997 , it has not been extensively studied independent of other IE proteins in the context of a viral infection. A limited number of cellular factors have been linked to ICP0's transactivation activity (Davido et al., 2002 , Li et al., 2009 ; however, the development of a cell-based assay to monitor this activity would allow for the systematic identification of key cellular factors or activities (e.g., via siRNA knockdown) that contribute to this function.
To begin to elucidate cellular factors that affect ICP0's transactivating activity, we have developed an assay that measures this activity of ICP0 in a 96-well plate format. The assay was developed using two HSV-1 reporter viruses that express only ICP0 of the 5 IE genes (d106) or none of the IE genes (d109). Both viruses have a human cytomegalovirus major immediate early promoter (HCMV MIEp) driven green fluorescent protein (GFP) in the HSV-1 ICP27 locus (Samaniego et al., 1998) . Similar to other published reports (Eidson et al., 2002 , Everett et al., 2009 , Minaker et al., 2005 , Preston and Nicholl, 1997 , we show here that ICP0 is capable of transactivating the HCMV MIEp; in the case of d106, ICP0 transactivation activity is quantified by measuring GFP fluorescence levels using a Typhoon Imager. To ultimately adapt this screen to use siRNAs against cell targets, we demonstrate that ICP0's transactivating activity was minimally affected when cells were transfected with an siRNA against the cellular house keeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Using a 96-well plate format, we established that d106 (+ICP0) has higher levels of GFP than d109 (-ICP0), which increase from 12 to 24 h post infection (hpi). Lastly, we use this assay in an siRNA library screen and identify that an siRNA against ubiquitin activating enzyme E1-like (UBEL1) impairs the transactivation activity of ICP0, validating the development of our assay.
Materials and methods

Cell culture and viruses
HeLa S3 (human cervical carcinoma) cells (kindly provided by Ira Blader) were utilized in the assay and grown in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum (FBS), 2 mM L-glutamine, 10 U/mL penicillin, 10 U/mL streptomycin, and 50 μg/mL gentamycin at a temperature of 37°C in 5% CO 2 .
HSV-1 recombinant viruses, d106 and d109 (Fig 1, modified (Samaniego et al., 1998) , kindly provided by Neal DeLuca) were used in our cell-based assay. Of the 5 IE genes, d106 only expresses ICP0 (+ICP0), whereas d109 does not express any IE proteins (-ICP0). Both viruses express the GFP gene from the human cytomegalovirus major IE promoter (HCMV MIEp). Both d106 and d109 viruses were grown on M17 cells, which are a derivative of Vero cells stably transformed with the HSV-1 ICP4 and ICP27 genes (kindly provided by David Leib). Adenoviral vectors, Ad-crtTA and Ad-T-ICP0, were used to infect M17 and transiently express ICP0 to increase titers of d109. Ad-crtTA and Ad-TICP0 were grown and titered as previously described (Halford et al., 2001) . d106 was titered on Vero cells and d109 was titered on L7 cells (Vero cells that contain the ICP0 gene) (Samaniego et al., 1997) , and fluorescent forming units were counted 24 hpi. M17, Vero, and L7 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) containing 5% fetal bovine serum (FBS), 2 mM L-glutamine, 10 U/mL penicillin, 10 U/mL streptomycin, and 50 μg/mL gentamycin at a temperature of 37°C in 5% CO 2 .
Reverse transfection
HeLa S3 cells were reverse tranfected in BD Falcon black well clear bottom optilux 96-well plates (San Jose, California, catalog # 08-772-104). Ambion siRNAs (Grand Island, NY) were used at a volume of 10 μL per well and final concentration of 10 μM per well. The ubiquitin pathway siRNA library (Ambion, Grand Island, NY, Catalog number #AM80991V3) was used at the same volume and concentration. siRNA was pre-plated in wells of the 96-well plate. 0.2 μL of Lipofectamine 2000 per well was mixed with 9.8 μL Opti-MEM per well for 10-25 min. The Lipofectamine 2000/Opti-MEM mix is added to the pre-plated siRNA and allowed to incubate for 20 minutes. After the 20 min incubation, HeLa S3 cells were added to the wells at 8,000 cells per well in 80 μL per well in penicillin/ streptomycin free 10% FBS DMEM. Transfected and mock-transfected wells were washed twice with complete medium 24 h post transfection (hpt) and then 100 μL of HeLa S3 cell medium was added to each well. 48 hpt, medium was removed from the cells and the well was either infected with previously described reporter viruses or harvested for RNA isolation.
Infection
HeLa S3 cells were infected 48 hpt with d106 or d109 reporter viruses at a multiplicity of infection (MOI) of 1. Viruses were diluted in HeLa S3 medium that did not contain phenol red. Infections were allowed to proceed for 12, 18, and 24 hpi.
Detection and analysis of fluorescent signals
Plates were scanned using a Typhoon image scanner (General Electric Healthcare) at standard settings according the manufacturer's recommendations. Settings were chosen to scan green fluorescence at an excitation of 488, emission of 520, and photomultiplier tube (PMT) of 475 and excitation of 633, emission of 670, and photomultiplier tube (PMT) of 475 for the deep red. Scans were done at 12, 18, and 24 hpi. At the 24 h time point for the siRNA screen, cells were stained with deep red mitotracker in FBS-free DMEM at a final concentration of 250 nM as per protocol (Invitrogen, Grand Island, NY, catalog # M22426) to account for cell density. The fluorescence intensity of each scanned well was analyzed in ImageJ by using a circle the size of the well & measuring the intensity of each well. Data was copied into Excel (Microsoft) software for analysis. Wells that contained only cells and medium were used as background controls, and this value was subtracted from values of infected wells. For the siRNA screen, the GFP intensity was normalized to the mitotracker (deep red) intensity. d106 values were set at 100% and mock transfected, GAPDH siRNA transfected d106, d109 values were compared to the 100% value. For the siRNA screen, similar calculations were done, but normalized values were used instead of GFP only values. Lastly, the percent average variation for all d106 signals using the data in presented in Fig. 5 was calculated to be 3% of the mean d106 signal..
RNA isolation and reverse transcription real time PCR
Cells were lysed and harvested using Trizol (Invitrogen, Grand Island, NY) according to manufacturer's recommendations. RNA was isolated using phenol-chlorform extraction. 500 ng of RNA was reverse transcribed to make cDNA using the iScript BioRad cDNA synthesis kit (BioRad, Hercules, CA, catalog # 170-8890) according to manufacturer's conditions. Real time PCR was done by using SYBR green master mix (Roche) and standard conditions were used for the cellular target, GAPDH (5′ CGGATTTGGTCGTATTGGGCGC 3′ and 5′ TCCCGTTCTCAGCCTTGACGGT 3′), and the normalization control, hTBP (5′-TGCACAGGAGCCAAGAGTGAA-3′ and 5′-CACATCACAGCTCCCCACCA-3′) (Smith et al., 2013) . Standard curves were obtained for the target and normalization control. Comparisons were made using the ΔΔ2 CT method, setting the untransfected control at 100%.
Results
ICP0 transactivates the HCMV MIEp-GFP
With the long-term goal of identifying cellular factors that play a role in the transactivating activity of ICP0, we sought to develop a 96-well plate cell-based assay. We initially wanted to establish if the replication-defective reporter viruses, d106 (+ICP0) and d109 (-ICP0) (Samaniego et al., 1998) , could be used in this format. Specifically, we wanted to use fluorescence as an output of ICP0's transactivation activity. Both d106 and d109 viruses contain an HCMV MIEp-GFP reporter, and previous studies indicate that ICP0 can transactivate the HCMV MIEp (Fig. 1) . We first tested whether the expression of GFP is dependent on ICP0 in HeLa cells, a cell type commonly used to study HSV-1 replication that is highly transfectable for nucleic acids (e.g., siRNA and DNA plasmids) (Everett, 1987 , Sarma et al., 2008 . HeLa S3 cells were infected with d106 (+ICP0) or d109 (-ICP0), and GFP expression was examined by microscopy at 2, 6, 12, and 24 h post infection (hpi). Activation of the HCMV MIEp-GFP was first detected by 6 hpi for d106 (+ICP0) and steadily increased until 24 hpi (Fig. 2) . In contrast, activation of HCMV MIEp-GFP in d109 (-ICP0) became apparent by 12 hpi in a subset of cells (Fig 2) , with increased GFP expression by 24 hpi (Fig. 2) . Although the GFP is induced in d109 (-ICP0)-infected cells, it does not reach the level, both in relative fluorescence intensity and cell number, as d106 (+ICP0)-infected cells. This experiment indicated that ICP0 potently induced the HCMV MIEp-GFP reporter construct in d106; thus, we established that d106 can be used as a reporter virus for monitoring ICP0 transactivating activity.
siRNA depletion of GAPDH does not appear to affect ICP0's transactivation activity by fluorescence microscopy
We next wanted to know if transfecting an siRNA against a cellular housekeeping gene would affect the transactivating activity of ICP0. For this experiment, HeLa S3 cells were untransfected, mock transfected, or transfected with an siRNA targeted against GAPDH. Mock-transfected cells were included in these experiments to determine if the transfection reagent alone modulated ICP0's transactivating activity. As indicated in Figure 3 , we observed no notable differences in GFP levels of d106 (+ICP0)-or d109 (-ICP0)-infected cells that were untransfected, mock transfected, and GAPDH siRNA-transfected via microscopy.
GAPDH transcript levels are depleted in a 96-well plate format
Once we showed that transfection of siRNAs into cells did not appear to affect GFP levels of d106 (+ICP0) or d109 (-ICP0)-infected cells as imaged by microscopy, we next wanted to confirm that we could deplete the transcript levels of a cellular target using an siRNA in a 96-well plate format. HeLa S3 cells were untransfected, mock transfected, or transfected with a siRNA targeting GAPDH in triplicate wells. Forty-eight h post transfection (hpt), RNA from each well was isolated, reverse transcribed into cDNA, and analyzed by Real Time PCR. Transcript levels of GAPDH were significantly reduced to 3.4% of untransfected levels in the siRNA-transfected samples and to 75% in mock-transfected samples compared to untransfected samples, which were given the value of 100% (Fig. 4) . This experiment shows that we are able to reduce mRNA levels of a specific cellular target in a 96-well plate substantially.
An siRNA against GAPDH has a minimal affect on ICP0's transactivation activity in a 96-well plate
After we established that an siRNA against GAPDH depleted its transcript levels using a 96-well plate, we adapted this assay using the d106 and d109 reporter viruses to a 96-well plate format. HeLa S3 cells were untransfected, mock transfected, or transfected with a siRNA against GAPDH. At 48 hpt, HeLa S3 cells were mock infected in triplicate or infected with d106 or d109 at an MOI of 1. The 96-well plate was scanned for fluorescence using a Typhoon Imager at 12 hpi, 18 hpi, and 24 hpi. GFP expression was detected at 12 hpi for d106 (+ICP0) (Fig. 5A ), which gradually increased at 18 and 24 hpi (Fig. 5A ). For each time point, d106 (+ICP0) GFP levels are visibly higher than d109 (-ICP0), with d109 GFP intensities were reduced 5-6 fold at 12 hpi, 9.5-12 fold at 18 hpi, and 10.4-14 fold at 24 hpi ( Fig. 5B ) relative to d106, whether in the absence or presence of the GADPH siRNA. Lastly, there results confirmed our microscopy studies in which an siRNA against GAPDH did not appreciably affect GFP intensities for d106-or d109-infected wells compared their respective untransfected controls (Fig. 5B ). These experiments demonstrate that we can examine the transactivation activity of ICP0 using d106 in a cell-based assay in a 96-well plate format.
An siRNA agajnst UBE1L impairs the transactivation activity of ICP0
Utilizing our 96-well plate cell-based assay, we screened a small siRNA library that targeted components of the ubitiquitin pathway. Wells were reverse-transfected and infected with d106. From this screen, an siRNA against UBE1L, an E1 enzyme of the ubiquitinproteasome pathway, impaired the transactivation activity of ICP0 5.5-fold at 24 hpi (Fig.  6) , which began to approach d109 (-ICP0) GFP levels (Fig. 6) . Thus, we demonstrate that this assay can be used in an siRNA screen having identified a target in the ubiquitinproteasome pathway.
Discussion
In this paper, we have demonstrated, in line with other studies (Everett et al., 2009 , Minaker et al., 2005 , Preston and Nicholl, 1997 , that ICP0 can potently transactivate the HCMV MIEp (Fig. 2) . We also found that an siRNA against the housekeeping gene, GAPDH, does not appear to affect the transactivation activity of ICP0 as measured by microscopy ( Fig. 3) and that GAPDH transcripts could be depleted to significant levels in a 96-well plate format (Fig. 4) . These results indicate that siRNA technology can be used in this cell-based assay in a 96-well plate format. We also established that the Typhoon Imager is a quick and valid method to examine ICP0's transactivating activity in a 96-well plate format (Fig. 5) , and we verified that the assay can be used to screen an siRNA library by identifying an ubiquitinproteasome pathway target, UBE1L (Fig. 6) . Overall, we have concluded that the reporter viruses, d106 and d109, can be utilized in a cell-based assay by using a 96-well plate format and Typhoon image scanner.
While this system is adaptable to siRNA or small molecule inhibitor screens, this method also has several advantages over other established methods used to examine ICP0's transactivation activity (Davido et al., 2002 , Everett, 1987 , Jordan and Schaffer, 1997 . Specifically, ICP0's transactivation activity can be monitored in the context of a viral infection, in the absence of other IE proteins, and at multiple time points in one experiment or infection by the assaying of live cells. In contrast, other methods monitor this activity in the context of a viral infection but in the presence of other IE proteins (Davido et al., 2002) , which may complicate the interpretation of certain studies. Transient transfection reporter assays have been used to examine ICP0's transactivation activity independent of other IE proteins, but these assays are not done in the setting of a viral infection (Everett, 1987 , Jordan and Schaffer, 1997 . Finally, most viral reporter assays and transient transfection assays can only monitor one time point per sample because the cells will either have to be lysed or fixed to analyze the sample, in contrast to our system. Thus, the d106/d109 reporter assay is advantageous because it can be used to monitor multiple time points for one experiment and monitor ICP0's transactivation activity in the absence of IE proteins while in the context of a viral infection. Furthermore, the inclusion of d109 can also be used in counter-screens to verify that targets or inhibitors are specific for ICP0.
In summary, we have developed a cell-based assay for ICP0 that can use siRNA technology or small molecule inhibitors in a 96-well plate format. This assay can also be modified for use in a high throughput screen with the inclusion of viability indicators such as alamarBlue (Osaka and Hefty, 2013) . Notably, this assay will likely increase our knowledge related to the regulation of ICP0's transactivating activity, which may eventually lead to potential treatments against HSV-1 and its recurrent diseases.
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Highlights
• HSV-1 ICP0 potently transactivates an HCMV MIEp-GFP reporter construct in the HSV-1 mutant, d106.
• Using d106, ICP0 transactivation activity increases over time as determined by fluorescence microscopy and scanning.
• This reporter assay can be adapted to a 96-well plate format and is compatible with siRNA and inhibitor testing. Of the 5 IE genes, d106 only expresses ICP0 (ICP0+), whereas d109 does not express any IE proteins (ICP0-). Both viruses express the GFP gene from the human cytomegalovirus major IE promoter (HCMV MIEp). This figure is modified from Samaniego, et. al., 1998 . HeLa S3 cells were seeded in a 96-well plate. Cells were reverse transfected as described in the protocol. Wells that contained siRNA against the ubiquitin ligase pathway were infected with d106 at an MOI of 1, 48 hpt. Cells were untransfected or transfected with GAPDH siRNA for controls. 48 hpt, control wells were infected d106 or d109 or mock infected. The 96-well plate was scanned using a Typhoon Imager at 24 hpi. Comparisons were made relative to d106-untransfected infection, which was set at 100% (far left bar for each graph). UBEL1 is ubiquitin activating enzyme E1-like. Error bars represent SEMs. This experiment was repeated 3 times. 
